Eczema Trial, Recruiting NCT07347743 Sponsor: Universitair Ziekenhuis Brussel Condition: Eczema
Back to Eczema

Eczema Trial, Recruiting

NCT07347743
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • The baby was born at the UZ Brussel maternity ward at 37 weeks of pregnancy or later
  • The baby is in good health at the time of the initial check-up before the study begins
  • The baby is between 1 and 14 days old at the time of joining the study
  • The parent(s) or legal guardian(s) are able and willing to follow the study instructions throughout the trial
  • The baby has been assessed as suitable for the study by the research team
  • The parent(s) or legal guardian(s) are willing to avoid giving the baby any products containing probiotics from the first visit through to the last visit
  • The parent(s) or legal guardian(s) have provided written consent for the baby to take part

Who may not be able to join:

  • No parent or legal guardian is able to communicate in a local language used at the trial site
  • The baby has a major condition present from birth (such as anal atresia or Down syndrome), or there is a suspicion of a long-term condition or illness (such as Hirschsprung's disease or a metabolic disorder)
  • The baby has an immune system that does not work properly, either from birth or developed after birth
  • The baby has had an infection at the time of the initial check-up or within the 7 days before it
  • The baby has been admitted to the neonatal intensive care unit after birth
  • The research team has assessed the baby as not suitable for the study for any other reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Koen Huysentruyt, Pediatric Gastroenterologist, Universitair Ziekenhuis Brussel

Phone: +32 02/476.37.17

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Universitair Ziekenhuis Brussel
Registry
ClinicalTrials.gov
Start date
31 January 2026
Est. completion
1 May 2028

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Peak measured crying time; The occurrence of infant colic at any time in the first 3 months of life.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov